NCT06934642View on ClinicalTrials.gov

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
MASLDObesity
Interventions
DRUG

Tirzepatide

The drug is being studied to better understand the biological effects of tirzepatide on MASLD.

Trial Locations (1)

87131

RECRUITING

University of New Mexico Health Sciences Center, Albuquerque

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

collaborator

University of New Mexico Cancer Center

OTHER

lead

University of New Mexico

OTHER

NCT06934642 - Effect of Tirzepatide on Markers of MASLD in Patients With Obesity | Biotech Hunter | Biotech Hunter